Catalyst Wire Dossier Catalyst Wire Dossier

Personalized immunotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Personalized immunotherapy, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Personalized Immunotherapy in Patients With Recurrent /Metastatic SCCHN That Have Progressed on Prior Immunotherapy [Phase 2]

See pricing